Are there gender and race differences in cellular immunity patterns over age in infected and uninfected children born to HIV-infected women?

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 5, 2003, Pages 635-641

  Gray, Linsay ^b   Newell, Marie Louise ^a   Cortina Borja, Mario ^b   Thome, Claire ^b   Peckham, Catherine ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

Europe; Gender; Pediatric; Race; Vertically acquired infection

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CD8 ANTIGEN;

AGE; ARTICLE; CELLULAR IMMUNITY; CHILD; CHILDHOOD; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEALTH STATUS; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFANT; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MODEL; NEGRO; NEWBORN; PREMATURITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; SEX DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; INFANT; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEX FACTORS; T-LYMPHOCYTES;

EID: 0042627729     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200308150-00013     Document Type: Article

References (21)

1. Pitt J, Moye J, Matthews Y, et al. Gender differences in immunologic and virologic markers in children born to women infected by HIV. Paper presented at: 8th Conference on Retroviruses and Opportunistic Infections; Chicago, IL, February 4-8, 2001.
2. Centers For Disease Control. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep. 1994;43:RR12.
3. French Pediatric HIV Infection Study Group and the European Collaborative Study. Morbidity and mortality in European children vertically infected by HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:442-450.
4. European Collaborative Study. Fluctuations in symptoms in HIV-infected children: the first 10 years of life. Pediatrics. 2001;108:116-122.
5. European Collaborative Study. Level and pattern of RNA viral load over age: differences between girls and boys? AIDS. 2002;16:97-104.
6. The European Collaborative Study. Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. Pediatr Infect Dis J. 1992;11:1018-1026.
7. European Collaborative Study. HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS. 2001;15:761-770.
8. Friedman JH. A Variable Span Smoother. Palo Alto, CA: Laboratory for Computational Statistics, Dept. of Statistics, Stanford University; 1984. Technical Report No. 5.
9. de Boor C. A Practical Guide to Splines. Berlin: Springer Verlag; 1978.
10. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963-974.
11. Waecker NJJ, Ascher DP, et al., for the Military Pediatric HIV Consortium. Age-adjusted CD4+ lymphocyte parameters in healthy children at risk for infection with the human immunodeficiency virus. Clin Infect Dis. 1993;17:123-125.
12. Bartlett JA, Goldklang AR, Schleifer SJ, et al. Immune function in healthy inner-city children. Clin Diagn Lab Immunol. 2001;8:740-746.
13. Lepage P, Van de Perre P, Msellati P, et al. Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) and its determinants: a cohort study in Kigali, Rwanda. Am J Epidemiol. 1993;137:589-599.
14. European Collaborative Study. Clinical and immunological characteristics of HIV infected pregnant women. Br J Obstetr Gynaecol. 1995;101:869-875.
15. Leroy V, Karon JM, Alioum A, et al. Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS. 2002;16:631-641.
16. Gesner M, Papaevangelou V, Kim M, et al. Alteration in the proportion of CD4 T lymphocytes in a subgroup of human immunodeficiency virus-exposed-uninfected children. Pediatrics. 1994;93:624-630.
17. Embree J, Bwayo J, Nagelkerke N, et al. Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi. Pediatr Infect Dis J. 2001;20:397-403.
18. Douglas SD, Rudy B, Muenz L, et al., for the Adolescent Medicine HIV/ AIDS Research Network. Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. AIDS. 1999;13:1629-1635.
19. Jennings C, Rich K, Siegel J-N, et al. A phenotypic study of CD8+ lymphocyte subsets in infants using three-color flow cytometry. Clin Immunol Immunopathol. 1994;71:8-13.
20. Fletcher M-A, Mosley J-W, Hassett J, et al. Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group. BMJ. 1992;80:831-840.
21. Paediatric European Network for Treatment of AIDS. PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. HIV Med. 2002;3:215-226.